Exchange: NYSE·Updated 04:10 PM EDT
FMS logo

FMSFresenius Medical Care AG & Co. KGAA

$24.02
$0.11
(0.46%)
Today
Closed $24.02
$0.00
(0.00%)
After Hours
EarningsAug 4
Mkt Cap$11.73B
Vol311,961.00
News
all
press releases
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
FMS??? margin gains, HighVolumeHDF rollout and AI-driven care are boosting momentum, but reimbursement and volume risks remain.
Zacks
News Placeholder
More News
News Placeholder
DaVita Stock Benefits From Strengthening Kidney Care Delivery
DVA is advancing kidney care through IKC expansion, CMS CKCC progress and AI-driven dialysis scheduling improvements.
Zacks
News Placeholder
DVA vs. FMS: Which Dialysis Leader Is Better Positioned Now?
DaVita and Fresenius Medical Care are taking different paths in kidney care, but which stock offers stronger upside now? Let's dive in.
Zacks
News Placeholder
FMS and Home Dialysis: How 5008X Could Reset Demand
FMS scales 5008X high-volume HDF and expands home dialysis, aiming for benefits later in 2026 and a bigger payoff in 2027+.
Zacks
News Placeholder
FMS Launches kinexus Digital Platform for Home Dialysis Care
Fresenius Medical Care launches kinexus, a home dialysis platform integrating remote monitoring, prescription management and supply ordering for PD and HHD.
Zacks
News Placeholder
DaVita Expands Comprehensive Kidney Care Through Dialysis Services
DVA expands kidney-care reach with integrated CKD/ESKD coordination and 2026 AI scheduling tech to boost dialysis efficiency.
Zacks
News Placeholder
DaVita Gains 21.4% in Three Months: How Should You Play the Stock?
DVA raises guidance on stronger dialysis volumes and reimbursement gains, but rising patient-care and technology costs could squeeze margins.
Zacks
News Placeholder
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Posts Earnings Results, Misses Expectations By $0.06 EPS
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) posted its earnings results on Tuesday. The company reported $0.53 earnings per share for the quarter, missing analysts' consensus estimates of $0.59 by ($0.06). The company had revenue of $5.34 billion for the quarter, compared to...
MarketBeat
News Placeholder
FMS Stock Rises Despite Q1 Earnings & Sales Miss, Margins Expand
Fresenius Medical's shares rise after Q1 earnings miss estimates as margin expansion and FME25+ savings support operating income growth.
Zacks
News Placeholder
Relative Strength Alert For Fresenius Medical Care
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets
<
1
2
...
>

Advertisement|Remove ads.